StonvexLoading…
StonvexStonvexStonvexCore line items from TZOO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $25.57M | $24.27M | $91.72M | $69.25M | $47.05M |
Operating Income | Not available | $3.44M | $6.90M | $6.35M | $5.86M |
Net Income | Not available | $2.48M | $4.70M | $4.72M | $4.57M |
EPS (Diluted) | $0.12 | $0.23 | $0.41 | $0.39 | $0.38 |
Total Assets | Not available | $50.87M | $45.19M | $46.16M | $46.73M |
Total Liabilities | Not available | $54.02M | $47.61M | $49.25M | $48.82M |
Cash & Equivalents | Not available | $10.57M | $10.01M | $8.49M | $10.44M |
Free Cash Flow OCF − CapEx | Not available | $3.84M | $5.60M | $4.16M | $4.55M |
Shares Outstanding | Not available | 10.43M | 10.93M | 10.93M | 11.08M |